MedPharm, a Colorado-based cannabis research and formulation development company, announced Aug. 27 that it received word from the Drug Enforcement Administration (DEA) and has been selected to receive a license to grow cannabis for research. This comes after the DEA's Aug. 26 announcement that it will take steps to expand the scientific and medical research of cannabis with a promise to approve additional federal cultivation licenses from a pool of 33 applications, most of which have been pend...
Browse Article Categories
Colorado-Based MedPharm Has Big Plans for Cannabis Research
Rate this article
No Comments Yet
Be the first to share what you think!